Trial intelligence / Profile preview

Ultrasound-guided bilateral transversus thoracis muscle plane block via catheter and postoperative pain in cardiac surgery

2020-004178-23Phase 4Completed

Sponsor
Turku University Hospital
Start
Feb 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of ropivacaine in Cardiac valve disease (VHD) and cardiac disease, sponsored by Turku University Hospital. Primary endpoint: Pain scores at rest and on movement. Started Feb 2021; status: completed.

02

Drugs

ropivacaine
03

Conditions

Cardiac valve disease (VHD)cardiac disease

Beyond the preview

Go deeper on 2020-004178-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-004178-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call